Literature DB >> 6540514

Prognosis in hypertrophic cardiomyopathy.

Y Koga, K Itaya, H Toshima.   

Abstract

One hundred thirty-six patients with hypertrophic cardiomyopathy were followed up for 1 to 17 years. Twenty-one patients had died, 14 of them suddenly, two from heart failure, two from cerebral embolism, and three from noncardiac causes. Life table analysis revealed that sudden death was significantly associated with young age less than 20 years (relative risk [rr] = 8.63, when compared with those greater than 40 years) and with positive Master's single two-step test (rr = 3.55). Heart failure was more frequent in patients with positive Master's single test (rr = 4.27) and with left ventricular end-diastolic pressure greater than 20 mm Hg (rr = 2.58). Atrial fibrillation, observed in 15 patients, was a poor prognostic sign, resulting in five cardiac deaths and seven heart failures. In contrast, prognosis was favorable in patients with apical hypertrophy with giant negative T wave. Thus Japanese patients with hypertrophic cardiomyopathy showed a prognosis consistent with Western patients, except for excellent outcome of apical hypertrophy.

Entities:  

Mesh:

Year:  1984        PMID: 6540514     DOI: 10.1016/0002-8703(84)90624-0

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  13 in total

Review 1.  Hypertrophic cardiomyopathy in daily practice: an introduction on diagnosis, prognosis and treatment.

Authors:  C van der Lee; M J Kofflard; M L Geleijnse; F J Ten Cate
Journal:  Neth Heart J       Date:  2005-12       Impact factor: 2.380

2.  Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review.

Authors:  Patricia Alphonse; Sohaib Virk; Jhonna Collins; Timothy Campbell; Stuart P Thomas; Christopher Semsarian; Saurabh Kumar
Journal:  Clin Res Cardiol       Date:  2020-09-03       Impact factor: 5.460

3.  Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy.

Authors:  P M Elliott; J R Gimeno; R Thaman; J Shah; D Ward; S Dickie; M T Tome Esteban; W J McKenna
Journal:  Heart       Date:  2005-10-10       Impact factor: 5.994

4.  Natural history of hypertrophic cardiomyopathy.

Authors:  P M Elliott
Journal:  Curr Cardiol Rep       Date:  2000-03       Impact factor: 2.931

Review 5.  The role of pharmacologic treatment to prevent sudden death in the implantable cardioverter defibrillator era.

Authors:  P M Elliott
Journal:  Curr Cardiol Rep       Date:  2001-03       Impact factor: 2.931

6.  Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.

Authors:  T Nishimura; S Nagata; T Uehara; T Morozumi; Y Ishida; T Nakata; O Iimura; C Kurata; Y Wakabayashi; H Sugihara; K Otsuki; T Wada; Y Koga
Journal:  Ann Nucl Med       Date:  1996-02       Impact factor: 2.668

7.  Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications?

Authors:  Guillermo Romero-Farina; Jaume Candell-Riera; Enrique Galve; Lluís Armadans; Francisca Ramos; Joan Castell; Santiago Aguadé; Juan M Nogales; Jordi Soler-Soler
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

8.  Myocardial perfusion SPECT in the diagnosis of apical hypertrophic cardiomyopathy.

Authors:  Tomás F Cianciulli; María C Saccheri; Osvaldo H Masoli; Marcela F Redruello; Jorge A Lax; Luis A Morita; Juan A Gagliardi; Adriana N Dorelle; Horacio A Prezioso; Luis A Vidal
Journal:  J Nucl Cardiol       Date:  2009-01-09       Impact factor: 5.952

9.  Progression from hypertrophic cardiomyopathy to dilated cardiomyopathy.

Authors:  L L Cregler
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

10.  Impaired myocardial perfusion in patients with hypertrophic cardiomyopathy: assessment with digital subtraction coronary arteriography.

Authors:  H Ikeda; M Shimamatsu; O Yoshiga; K Shibao; Y Koga; H Toshima
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.